Latest news for Contel Technology Co (OTC:CNTCF) Stock

Contel Technology Co Ltd is mainly engaged in sourcing and sale of integrated circuit (IC) products. It specializes in providing IC application solutions and IC-related services in five main categories: mobile devices and smart charging products; motor control; sensors and automation; light-emitting diode; radio frequency (RF) power.

CONTEL TECHNOLOGY CO LTD by Contel Technology Co Ltd.

Contel Technology Co Ltd

Truist Securities analyst Terry Tillman downgrades Instructure Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INST#NYSE">INST</a>) from Buy to Hold and lowers the price target from $35 to $23.6.

News

Downgrades

Price Target

Analyst Ratings

INST

Truist Securities Downgrades Instructure Hldgs to Hold, Lowers Price Target to $23.6

CNA Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNA#NYSE">CNA</a>) reported quarterly earnings of $1.67 per share which beat the analyst consensus estimate of $1.23 by 35.77 percent. This is a 47.79 percent increase over earnings of $1.13 per share from the same period last year. The company reported quarterly sales of $4.27 billion which beat the analyst consensus estimate of $3.55 billion by 20.20 percent. This is a 29.15 percent increase over sales of $3.30 billion the same period last year.

Earnings

Earnings Beats

CNA Financial Q2 EPS $1.67 Beats $1.23 Estimate, Sales $4.27B Beat $3.55B Estimate

Positive high-level results from an interim analysis of the AMPLIFY Phase III trial showed a fixed duration of AstraZeneca&rsquo;s&nbsp;Calquence&nbsp;(acalabrutinib) in combination with venetoclax, with or without obinutuzumab, demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to standard-of-care chemoimmunotherapy in previously untreated adult patients with chronic lymphocytic leukaemia (CLL).
For the secondary endpoint of overall survival (OS), a trend was observed in favour of&nbsp;Calquence&nbsp;in combination with venetoclax, with or without obinutuzumab, versus standard-of-care chemoimmunotherapy. The OS data were not mature at the time of this analysis and the trial will continue to assess OS as a key secondary endpoint.

Biotech

Large Cap

Health Care

General

AstraZeneca's Interim Analysis Of Amplify Phase 3 Trial Showed A Fixed Duration Of Calquence Plus Venetoclax, With Or Without Obinutuzumab, Improved Progression-Free Survival Vs. Standard Chemoimmunotherapy In Untreated Chronic Lymphocytic Leukemia

HC Wainwright &amp; Co. analyst Scott Buck reiterates SoundHound AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) with a Buy and maintains $7 price target.

Reiteration

SOUN

HC Wainwright & Co. Reiterates Buy on SoundHound AI, Maintains $7 Price Target

Guidance

VinFast To Restate Unaudited Financial Statements For Q1 Fiscal 2024;  Board Concluded Financial Statements For Year Ended Dec 2023, Quarter Ended March Should No Longer Be Relied Upon

HC Wainwright &amp; Co. analyst Ed Arce reiterates Genfit (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNFT#NASDAQ">GNFT</a>) with a Buy and maintains $13 price target.

GNFT

HC Wainwright & Co. Reiterates Buy on Genfit, Maintains $13 Price Target

abc dental was established in 1998 and had sales in 2023 of approximately $27.5 million, the majority of which were from dental consumable merchandise and equipment, with further revenue from the design and customization of dental practices and dental laboratory installations. Henry Schein acquired 100% of abc dental from ADMETOS GmbH. Henry Schein expects the transaction to be neutral to 2024 non-GAAP earnings per share and accretive thereafter. Financial terms were not disclosed.
The acquisition of abc dental, based in Schlieren, Switzerland, builds upon Henry Schein&#39;s 2022 acquisition of Condor Dental, based in Vouvry, Switzerland. abc dental will extend Henry Schein&#39;s ability to deliver a wider range of solutions and services to customers in Switzerland.

HSIC

Henry Schein Has Acquired abc dental AG, A Full-service Dental Distributor Offering Consumables, Equipment, And Technical Service To General Practitioners, Specialists, And Dental Laboratories In Switzerland, Financial Terms Were Not Disclosed

Last week, tech YouTuber Marques Brownlee, popularly known as MKBHD, finally revealed why he was contacted by the Federal Bureau of Investigation (FBI) in 2020.
What Happened: In the video, Brownlee said that the FBI had approached him to discuss the Escobar Inc. phone. The agency asked to examine all communications between his team and the company and confiscated the devices for a fraud investigation.
Back in March 2020, Brownlee showcased the $399 Pablo Escobar Fold 2, a gold Android phone that bore a striking resemblance to the Samsung Galaxy Fold. The device was named after the infamous Colombian drug lord Pablo Escobar.
It was later discovered that the device was essentially a Galaxy Fold with a gold sticker on the back and hinge. There was another phone, called Pablo Escobar Gold 11 Pro, which was in reality an iPhone 11 Pro.
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/07/39926002/after-donald-trumps-recent-taiwan-statement-sent-shockwaves-japans-pm-kishida-reveals-new-bill-to-bo?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">After Donald Trump&#8217;s Recent Taiwan Statement Sent Shockwaves, Japan&#8217;s PM Kishida Reveals New Bill To Boost AI And Chipmaking With Domestic Investment</a>
Brownlee had previously hinted at&nbsp;his interaction with the FBI, but his comments were largely dismissed as jokes. He&nbsp;stated that the company was&nbsp;allegedly sending phones to YouTubers and others for positive reviews, while reportedly failing to deliver devices to other customers.
&#8220;As I uncovered in my video, [Escobar Inc.] was covering Samsung Galaxy folds, cheaply with gold stickers, and then shipping them to YouTubers and people who they believed would talk about it positively.&#8221;
&#8220;Those people were getting scammed out of their money. And honestly, in hindsight, I don&#8217;t know how they thought they were gonna get away with this,&#8221; Brownlee added.
In February 2024, Olof Gustafsson, the CEO&nbsp;of Escobar was arrested on charges of fraud,&nbsp;smuggling, money laundering, and illegal&nbsp;art trading, following allegations of failing to deliver phones to customers.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It&#8217;s Important: At the time of writing, Brownlee&#8217;s YouTube channel had 19.2 million subscribers. At the end of the video, Brownlee also hinted that this wasn&#8217;t the only time he had a run-in with FBI agents.
However, the popular YouTuber didn&#8217;t give away many details and instead said, &#8220;That&#8217;s not the only encounter that we&#8217;ve had with the FBI in running this YouTube channel, but that&#8217;s another story for another day.&#8221;
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="My FBI Declassified Story" width="500" height="281" src="https://www.youtube.com/embed/_9prH7NFmLI?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39902838/broadcom-to-challenge-nvidia-dominance-analyst-says-jensen-huang-led-chip-giants-competitor-is-catch?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Broadcom To Challenge Nvidia Dominance? Analyst Says Jensen Huang-Led Chip Giant&#8217;s Competitor Is &#8216;Catching Up&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Tech

Popular Tech YouTuber Marques Brownlee Reveals Why FBI Knocked On His Door In 2020: It Has Something To Do With A $399 Android Phone

Second Quarter&nbsp;2024 Estimated Preliminary Financial Results:
<ul>
<li>Net revenue is estimated to total&nbsp;$4.0 million, as compared to&nbsp;$4.0 million&nbsp;for the&nbsp;first quarter&nbsp;of 2024 and&nbsp;$4.4 million&nbsp;for the&nbsp;second quarter&nbsp;of 2023.</li>
<li>GAAP loss from operations is estimated to range from&nbsp;($2.3)&nbsp;million to&nbsp;($2.1)&nbsp;million, as compared to&nbsp;($2.5)&nbsp;million for the&nbsp;first quarter&nbsp;of 2024 and&nbsp;($6.0)&nbsp;million for the&nbsp;second quarter&nbsp;of 2023.</li>
<li>Non-GAAP loss from operations is estimated to range from&nbsp;($1.9)&nbsp;million to&nbsp;($1.7)&nbsp;million, as compared to a non-GAAP loss from operations of&nbsp;($2.0)&nbsp;million for the&nbsp;first quarter&nbsp;of 2024 and&nbsp;($4.8)&nbsp;million for the&nbsp;second quarter&nbsp;of 2023.</li>
<li>Cash and cash equivalents are estimated to be&nbsp;$7.9 million&nbsp;as of June 30, 2024.</li>
</ul>

MRIN

Marin Software Reported Preliminary Q2 Revenue Of $4M Vs $4.4M YoY, Cash Balance Of $7.9M

WestPark Capital analyst Kevin Garrigan maintains Data I/O (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAIO#NASDAQ">DAIO</a>) with a Buy and lowers the price target from $5 to $4.

DAIO

WestPark Capital Maintains Buy on Data I/O, Lowers Price Target to $4

COLL

Collegium Pharmaceutical Agrees To Acquire Ironshore Therapeutics For $525M In Cash With The Potential For An Additional $25M Commercial Milestone Payment

RVTY

Revvity Updates Its 2024 Adjusted EPS Guidance To  $4.70-$4.80 Compared To Prior Guidance Of  $4.55-$4.75 And Consensus Of $4.63

2024&nbsp;Outlook
For the full year 2024, the Company is updating its revenue and adjusted EPS expectations to&nbsp;$1.609&nbsp;to&nbsp;$1.629 billion&nbsp;and&nbsp;$2.41&nbsp;to&nbsp;$2.57, respectively. The revenue range represents reported growth of&nbsp;4.4%&nbsp;to&nbsp;5.7%, with organic growth of &ndash;1.0%&nbsp;to&nbsp;0.3%, reflecting&nbsp;third quarter&nbsp;quality and labeling compliance shipping holds and significant second half investments in quality and compliance improvement.

IART

Integra LifeSciences Expects FY24 Revenue of $1.609B-$1.629B (Prior $1.672B-$1.687B) Vs $1.676B Est, Adj EPS of $2.41-$2.57 (Prior $3.01-$3.11) Vs $3.04 Est

Provident Finl Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROV#NASDAQ">PROV</a>) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $0.23 by 21.74 percent. The company reported quarterly sales of $9.918 million which beat the analyst consensus estimate of $9.430 million by 5.17 percent. This is a 4.35 percent decrease over sales of $10.369 million the same period last year.

PROV

Provident Finl Hldgs Q4 2024 GAAP EPS $0.28 Beats $0.23 Estimate, Sales $9.918M Beat $9.430M Estimate

Revvity Updates Its 2024 Sales Guidance To $2.77B-$2.79B Compared To Prior Guidance Of $2.76B-$2.82B And Consensus Of $2.793B

Dearborn-based Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>), known for its work trucks, has patented a method for detecting and responding to speeding violations.
What Happened: According to the patent application by Ford published on July 18, the processor in a vehicle can identify the speed of a second vehicle with the help of a vehicle speed detection system. The first vehicle can then operate a camera to capture an image of the second vehicle if the speed exceeds a threshold, the patent application proposed. 
The image could then be evaluated for identifying features of the second vehicle and a record generated including the speed measurement, the image, and the identifying feature. 
In certain cases, the record may be transmitted to another law-enforcement vehicle or an Internet-Of-Things (IoT) unit on the roadside, Ford said in the filing, to enable pursuit or tracking of the overspeeding vehicle.
Why It Matters: According to data from the U.S. auto safety regulator National Highway Traffic Safety Administration (NHTSA), speeding was a contributing factor in 29% of all traffic fatalities in 2022. This resulted in 12,151 people dying, and an estimated 300,595 being injured in speeding-related crashes throughout the year.
Ford is <a href="https://www.benzinga.com/markets/equities/24/07/39618985/ford-reports-q2-sales-growth-trucks-up-5-evs-surge-61-trails-tesla-in-volume">among the biggest automakers</a> in the U.S. The company sold 536,050 vehicles in total in the second quarter while its rival General Motors sold 696,086 units. 
The <a href="https://www.benzinga.com/news/24/01/36626761/tesla-ceo-elon-musk-mocks-fords-repossession-tech-that-turns-off-air-conditioning-cant-tell-real-fro">patent filed by Ford</a> to monitor overspeeding, however, might not be deployed on its large fleet. Patents aren&#8217;t necessarily indicative of a new business, product, or feature. 
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
Read More:
<ul>
<li><a href="https://www.benzinga.com/news/24/07/40004587/boeing-wins-space-mission-contracts-owing-to-its-armies-of-lobbyists-says-spacex-ceo-elon-musk-amid">Boeing Wins Space Mission Contracts Owing To Its &#8216;Armies Of Lobbyists,&#8217; Says SpaceX CEO Elon Musk Amid Starliner Return Delay</a></li>
</ul>
Photo courtesy: Unsplash

Ford Patents Innovative Technology To Detect and Report Speeding Drivers To Cops

Needham analyst James Ricchiuti maintains Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Buy and raises the price target from $48 to $57.

CGNX

Needham Maintains Buy on Cognex, Raises Price Target to $57

EHang Holdings Limited (&ldquo;EHang&rdquo; or the &ldquo;Company&rdquo;) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EH#NASDAQ">EH</a>), the world&rsquo;s leading urban air mobility (&ldquo;UAM&rdquo;) technology platform company, today announced that&nbsp;it has delivered the first batch of 10 units&nbsp;of&nbsp;EH216-S pilotless&nbsp;electric&nbsp;vertical&nbsp;takeoff&nbsp;and&nbsp;landing&nbsp;(&ldquo;eVTOL&rdquo;) aircraft to Taiyuan Xishan Ecological Tourism Investment Construction Co., Ltd. (&ldquo;Xishan Tourism&rdquo;) in the second quarter of this year, and&nbsp;completed&nbsp;debut passenger-carrying flights&nbsp;of EH216-S&nbsp;in Taiyuan, Shanxi&nbsp;on&nbsp;July 28, 2024.

First Batch of EHang's EH216-S Delivered to Xishan Tourism and Completed Debut Passenger-Carrying Flights in Taiyuan

2024&nbsp;Outlook
For the full year 2024, the Company is updating its revenue and adjusted EPS expectations to&nbsp;$1.609&nbsp;to&nbsp;$1.629 billion&nbsp;and&nbsp;$2.41&nbsp;to&nbsp;$2.57, respectively. The revenue range represents reported growth of&nbsp;4.4%&nbsp;to&nbsp;5.7%, with organic growth of &ndash;1.0%&nbsp;to&nbsp;0.3%, reflecting&nbsp;third quarter&nbsp;quality and labeling compliance shipping holds and significant second half investments in quality and compliance improvement.
For the&nbsp;third quarter&nbsp;2024, the Company expects reported revenues in the range of&nbsp;$372 million&nbsp;to&nbsp;$382 million, representing reported growth of&nbsp;-2.6%&nbsp;to&nbsp;0.0%&nbsp;and organic growth of&nbsp;-9.4%&nbsp;to &ndash;6.7%. The Company expects adjusted EPS in a range of&nbsp;$0.36&nbsp;to&nbsp;$0.44.
The Company&#39;s organic sales growth&nbsp;guidance&nbsp;for the&nbsp;third quarter&nbsp;and the full-year excludes acquisitions and divestitures, as well as the effects of foreign currency.

Integra LifeSciences Expects Q3 Revenue Of $372M-$382M Vs $432.11M Est, Adj EPS Of $0.36-$0.44 Vs $0.85 Est

Loews Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/L#NYSE">L</a>) announced today that, as part of its leadership succession plan, on December 31, 2024, James Tisch will retire as President and CEO and will be succeeded by Benjamin Tisch, current Senior Vice President, Corporate Development and Strategy. As part of the leadership transition, James Tisch will become Chairman of the Board of Directors, and Benjamin Tisch and Loews Hotels &amp; Co&#39;s CEO Alexander Tisch will join the Board. Also, Andrew Tisch and Jonathan Tisch will transition from Directors to Directors Emeriti.

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

Contel Technology Co

News

Latest news for Contel Technology Co (OTC:CNTCF) Stock